1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc.

AVIR
Atea Pharmaceuticals, Inc.US flagNASDAQ Global Select
4.21
USD
-0.06
- -
336.91MMarket Cap

Income Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
49
351
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
49
351
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-49
-351
- -
- -
- -
- -
- Operating Expenses
9
15
60
213
131
164
193
181
+ Selling, General & Admin
3
4
22
46
49
50
49
33
+ Research & Development
7
10
38
167
82
114
144
148
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-9
-15
-11
138
-131
-164
-193
-181
- Non-Operating (Income) Loss
- -
-1
- -
- -
-11
-29
-25
-16
+ Interest Expense, Net
- -
-1
- -
- -
-11
-29
-25
-16
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
1
- -
- -
11
29
25
16
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-9
-14
-11
139
-119
-135
-167
-165
- Income Tax Expense (Benefit)
- -
- -
- -
17
-4
1
1
-6
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-9
-14
-11
121
-116
-136
-168
-158
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-9
-14
-11
121
-116
-136
-168
-158
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-9
-14
-11
121
-116
-136
-168
-158
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-14
-11
121
-116
-136
-168
-158
EBIT
-9
-15
-11
138
-131
-164
-193
-181
EBITDA
-9
-15
-11
138
-130
-164
-193
-180
EBITDA Margin (%)
- -
- -
-22.64
39.39
- -
- -
- -
- -
EBITA
-9
-15
-11
138
-131
-164
-193
-181
Gross Margin (%)
- -
- -
100
100
- -
- -
- -
- -
Operating Margin (%)
- -
- -
-22.68
39.38
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-22.51
34.49
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
47
47
22
83
83
83
84
- -
Basic EPS, GAAP
-0.19
-0.3
-0.51
1.46
-1.39
-1.63
-2
- -
Basic EPS from Cont Ops
-0.19
-0.3
-0.51
1.46
-1.39
-1.63
-2
- -
Diluted Weighted Avg Shares
47
47
22
88
83
83
84
- -
Diluted EPS, GAAP
-0.19
-0.3
-0.51
1.37
-1.39
-1.63
-2
- -
Diluted EPS from Cont Ops
-0.19
-0.3
-0.51
1.37
-1.39
-1.63
-2
- -

Balance Sheet (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
35
22
863
772
661
590
462
311
+ Cash, Cash Equivalents & STI
34
22
850
764
647
578
455
302
+ Cash & Cash Equivalents
34
22
850
764
188
144
65
96
+ ST Investments
- -
- -
- -
- -
458
434
390
206
+ Accounts & Notes Receiv
- -
- -
6
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
6
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
8
8
14
12
8
9
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
6
5
2
4
+ Property, Plant & Equip, Net
- -
- -
- -
- -
4
3
2
1
+ Property, Plant & Equip
- -
- -
- -
- -
4
4
3
3
- Accumulated Depreciation
- -
- -
- -
- -
- -
1
1
2
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
2
1
- -
3
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
2
1
- -
3
Total Assets
35
22
864
773
667
595
465
315
+ Payables & Accruals
2
2
14
57
18
32
18
39
+ Accounts Payable
- -
1
- -
5
3
4
4
13
+ Accrued Taxes
- -
- -
- -
3
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
14
50
15
27
13
26
+ ST Debt
- -
- -
- -
- -
1
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
1
1
1
+ Other ST Liabilities
- -
- -
301
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
301
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
2
316
57
18
32
19
40
+ LT Debt
- -
- -
- -
- -
2
2
1
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
2
2
1
- -
+ Other LT Liabilities
69
69
- -
6
5
6
6
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
69
69
- -
6
5
6
6
- -
Total Noncurrent Liabilities
69
69
- -
6
8
7
7
- -
Total Liabilities
71
72
316
63
26
40
26
40
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
5
613
654
701
751
803
798
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
5
613
654
701
751
803
798
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-40
-54
-65
56
-60
-196
-364
-523
+ Other Equity
- -
- -
- -
- -
-1
- -
- -
- -
Equity Before Minority Interest
-36
-50
548
710
641
555
439
275
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-36
-50
548
710
641
555
439
275
Total Liabilities & Equity
35
22
864
773
667
595
465
315
Shares Outstanding
79
79
82
83
83
83
84
78
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
3
2
2
1
Net Debt
-34
-22
-850
-764
-188
-144
-65
-96
Net Debt to Equity
95.38
43.7
-155.19
-107.65
-29.42
-25.91
-14.74
-34.75
Tangible Common Equity Ratio
-103.73
-224.58
63.43
91.87
96.08
93.31
94.45
87.38
Current Ratio
19.71
9
2.73
13.58
35.77
18.24
24.85
7.82
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-9
-14
-11
121
-116
-136
-168
-158
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
7
40
41
34
40
9
+ Stock-Based Compensation
- -
1
7
40
47
49
52
21
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
-6
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
-5
-15
-12
-5
+ Chg in Non-Cash Work Cap
1
1
300
-248
-47
16
-7
16
+ (Inc) Dec in Accts Receiv
- -
- -
-6
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-7
- -
-6
2
6
-2
+ Inc (Dec) in Accts Payable
1
1
12
54
-40
14
-13
21
+ Inc (Dec) in Other
- -
- -
301
-302
-1
- -
- -
-3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-8
-13
297
-87
-121
-85
-135
-132
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
-2
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
-2
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
318
1
- -
- -
- -
-25
+ Increase in Capital Stock
- -
- -
318
1
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
-26
+ Net Change in LT Investment
- -
- -
- -
- -
-453
40
56
189
+ Dec in LT Investment
- -
- -
- -
- -
92
603
517
471
+ Inc in LT Investment
- -
- -
- -
- -
-545
-562
-461
-282
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
-455
40
56
189
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
27
- -
214
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
27
- -
532
1
- -
- -
- -
-26
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
20
-13
828
-86
-576
-45
-79
31
EBITDA
-9
-15
-11
138
-130
-164
-193
-180
EBITDA Margin (%)
- -
- -
-22.64
39.39
- -
- -
- -
- -
Free Cash Flow
-8
-13
297
-87
-123
-85
-135
-132
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
-87
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-13
297
-87
-123
-85
-135
-132
Free Cash Flow per Basic Share
-0.17
-0.27
13.74
-1.05
-1.48
-1.02
-1.61
- -
Price/Free Cash Flow
- -
- -
3.04
-9.07
-3.36
-2.98
-2.08
- -
Cash Flow to Net Income
0.87
0.91
-27.11
-0.72
1.04
0.63
0.8
0.83
Capital Expenditures
- -
- -
- -
- -
-2
- -
- -
- -